{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:14:46Z","timestamp":1793420086784,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,12]],"date-time":"2021-12-12T00:00:00Z","timestamp":1639267200000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016059"],"award-info":[{"award-number":["P30 CA016059"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA175033"],"award-info":[{"award-number":["CA175033"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA099326"],"award-info":[{"award-number":["CA099326"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA154708"],"award-info":[{"award-number":["CA154708"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-11-0481"],"award-info":[{"award-number":["W81XWH-11-0481"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016350","name":"VCU Massey Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016350","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jconrel.2020.11.043","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T02:36:05Z","timestamp":1606876565000},"page":"328-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["\u201cDouble-punch\u201d strategy for delivery of viral immunotherapy with prolonged tumor retention and enhanced transfection efficacy"],"prefix":"10.1016","volume":"329","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jconrel.2020.11.043_bb0005","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4161\/onci.20172","article-title":"Oncolytic adenoviruses: a potent form of tumor immunovirotherapy","volume":"1","author":"Cerullo","year":"2012","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jconrel.2020.11.043_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2016.06.009","article-title":"Recent advances in oncolytic adenovirus therapies for cancer","volume":"21","author":"Rosewell Shaw","year":"2016","journal-title":"Curr. Opin. Virol."},{"issue":"6","key":"10.1016\/j.jconrel.2020.11.043_bb0015","doi-asserted-by":"crossref","first-page":"8636","DOI":"10.1002\/jcp.27850","article-title":"Oncolytic adenovirus: a tool for cancer therapy in combination with other therapeutic approaches","volume":"234","author":"Goradel","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"14","key":"10.1016\/j.jconrel.2020.11.043_bb0020","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1158\/0008-5472.CAN-17-0468","article-title":"Oncolytic adenovirus and tumor-targeting immune modulatory therapy improve autologous cancer vaccination","volume":"77","author":"Jiang","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2020.11.043_bb0025","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4049\/jimmunol.166.1.490","article-title":"Characterization of heat shock protein 110 and glucose-regulated protein 170 as cancer vaccines and the effect of fever-range hyperthermia on vaccine activity","volume":"166","author":"Wang","year":"2001","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2020.11.043_bb0030","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/0008-5472.CAN-05-2609","article-title":"Chaperoning function of stress protein grp170, a member of the hsp70 superfamily, is responsible for its immunoadjuvant activity","volume":"66","author":"Park","year":"2006","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.jconrel.2020.11.043_bb0035","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.4049\/jimmunol.0903891","article-title":"Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen","volume":"184","author":"Wang","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2020.11.043_bb0040","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.177.3.1543","article-title":"Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma","volume":"177","author":"Wang","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.jconrel.2020.11.043_bb0045","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1158\/0008-5472.CAN-12-1740","article-title":"A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity","volume":"73","author":"Yu","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2020.11.043_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-398342-8.00002-1","article-title":"Adenovirus strategies for tissue-specific targeting","volume":"115","author":"Beatty","year":"2012","journal-title":"Adv. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2020.11.043_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/nnm-2019-0323","article-title":"Designer nanocarriers for navigating the systemic delivery of oncolytic viruses","volume":"15","author":"Howard","year":"2020","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.jconrel.2020.11.043_bb0060","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1021\/acs.nanolett.9b00145","article-title":"Genetically engineered cell membrane Nanovesicles for oncolytic adenovirus delivery: a versatile platform for cancer virotherapy","volume":"19","author":"Lv","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2020.11.043_bb0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2019.04.040","article-title":"Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration","volume":"305","author":"Na","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.11.043_bb0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biomaterials.2017.08.035","article-title":"Synergistic antitumor effect mediated by a paclitaxel-conjugated polymeric micelle-coated oncolytic adenovirus","volume":"145","author":"Kasala","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.11.043_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jconrel.2015.10.009","article-title":"Polymeric oncolytic adenovirus for cancer gene therapy","volume":"219","author":"Choi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.11.043_bb0080","series-title":"Adenoviral Vectors for Gene Therapy (Second Edition)","first-page":"707","article-title":"Polymer-anchored adenovirus as a therapeutic agent for Cancer gene therapy","author":"Kasala","year":"2016"},{"issue":"7","key":"10.1016\/j.jconrel.2020.11.043_bb0085","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1021\/acs.biomac.5b00538","article-title":"Oncolytic adenovirus coated with multidegradable bioreducible core-cross-linked polyethylenimine for cancer gene therapy","volume":"16","author":"Choi","year":"2015","journal-title":"Biomacromolecules"},{"issue":"21","key":"10.1016\/j.jconrel.2020.11.043_bb0090","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1016\/j.biomaterials.2014.03.060","article-title":"Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression","volume":"35","author":"Lee","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jconrel.2020.11.043_bb0095","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1073\/pnas.98.3.1200","article-title":"Polymer-based gene delivery with low cytotoxicity by a unique balance of side-chain termini","volume":"98","author":"Putnam","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.jconrel.2020.11.043_bb0100","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/adhm.201300046","article-title":"Mitigated cytotoxicity and tremendously enhanced gene transfection efficiency of PEI through facile one-step carbamate modification","volume":"2","author":"Yang","year":"2013","journal-title":"Adv. Healthc. Mater."},{"issue":"2","key":"10.1016\/j.jconrel.2020.11.043_bb0105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/bc7003236","article-title":"Disulfide cross-linked Polyethylenimines (PEI) prepared via Thiolation of low molecular weight PEI as highly efficient gene vectors","volume":"19","author":"Peng","year":"2008","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.jconrel.2020.11.043_bb0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/01480540903493507","article-title":"Comparative studies on the genotoxicity and cytotoxicity of polymeric gene carriers polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimer in Jurkat T-cells","volume":"33","author":"Choi","year":"2010","journal-title":"Drug Chem. Toxicol."},{"issue":"15","key":"10.1016\/j.jconrel.2020.11.043_bb0115","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.addr.2005.09.017","article-title":"Dendrimers in gene delivery","volume":"57","author":"Duf\u00e8s","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2020.11.043_bb0120","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1021\/cr500542t","article-title":"Surface-engineered dendrimers in gene delivery","volume":"115","author":"Yang","year":"2015","journal-title":"Chem. Rev."},{"issue":"4","key":"10.1016\/j.jconrel.2020.11.043_bb0125","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.molpharmaceut.8b01325","article-title":"Novel strategy of gene delivery system based on dendrimer loaded recombinant Hirudine plasmid for Thrombus targeting therapy","volume":"16","author":"Chen","year":"2019","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2020.11.043_bb0130","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/bit.27007","article-title":"Adhesive thermosensitive gels for local delivery of viral vectors","volume":"116","author":"Caronia","year":"2019","journal-title":"Biotechnol. Bioeng."},{"issue":"8","key":"10.1016\/j.jconrel.2020.11.043_bb0135","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1021\/nn5020787","article-title":"Injectable graphene oxide\/hydrogel-based Angiogenic gene delivery system for Vasculogenesis and cardiac repair","volume":"8","author":"Paul","year":"2014","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.jconrel.2020.11.043_bb0140","first-page":"952","article-title":"Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor","volume":"7","author":"Rakhmilevich","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2020.11.043_bb0145","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.colsurfb.2018.02.032","article-title":"Branched polyrotaxane hydrogels consisting of alpha-cyclodextrin and low-molecular-weight four-arm polyethylene glycol and the utility of their thixotropic property for controlled drug release","volume":"165","author":"Wang","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"7","key":"10.1016\/j.jconrel.2020.11.043_bb0150","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00262-010-0847-8","article-title":"Antitumor immunotherapy despite immunity to adenovirus using a novel adenoviral vector Ad5 [E1-, E2b-]-CEA","volume":"59","author":"Gabitzsch","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"issue":"20","key":"10.1016\/j.jconrel.2020.11.043_bb0155","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1128\/JVI.00783-12","article-title":"Circumventing Antivector immunity by using adenovirus-infected blood cells for repeated application of adenovirus-vectored vaccines: proof of concept in rhesus macaques","volume":"86","author":"Sun","year":"2012","journal-title":"J. Virol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:39:42Z","timestamp":1777509582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920306933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":31,"alternative-id":["S0168365920306933"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.11.043","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cDouble-punch\u201d strategy for delivery of viral immunotherapy with prolonged tumor retention and enhanced transfection efficacy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}